We have isolated a cDNA clone encoding the major protein-tyrosine-phosphatase (protein-tyrosine-phos- tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. M31724).
The phosphorylation of proteins at tyrosine has been recognized as an important regulatory component in signal transduction, neoplastic transformation, and, more recently, in the control ofthe mitotic cycle (1) (2) (3) (4) . As in systems regulated by serine or threonine phosphorylation, the phosphorylation of proteins at tyrosine is reversible, and protein-tyrosinephosphatases (PTPases; protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) from a variety of tissues and organisms have been described (for review, see ref. 5 ).
Although a general classification scheme for these enzymes
does not yet exist, there are apparently a number of protein phosphatases that are highly specific for phosphotyrosyl proteins and that bear little resemblance to either the proteinserine-or protein-threonine-phosphatases or the acid and alkaline phosphatases. In most tissues, the major PTPase (as measured in vitro by using a variety of artificial substrates) is a metal-ion-independent, vanadate-and molybdate-sensitive species of Mr 40,000. Recently, Tonks and coworkers (6, 7) have purified a form of this enzyme (PTP-1B) from human placenta and determined its amino acid sequence. The protein sequence is unrelated to those of other known phosphatases but is similar to the common leukocyte antigen (CD45) and to LAR, a homologue of the neural adhesion molecule (NCAM) (8) . The PTPase activity of CD45 has been verified experimentally (9) , and, recently, an additional member of the PTPase gene family has been cloned from human T cells (10) . In this report, we describe the cloning of the cDNA for the major human PTPase from human placenta. § MATERIALS AND METHODS Oligonucleotides. Oligonucleotides were synthesized on a Milligen (Bradford, MA) apparatus by using phosphoramidite chemistry and were purified with phenyl solid-phase extraction (J. T. Baker) columns (11 (12) . Two hundred thousand plaques of a human placental cDNA library in Agtll (Clontech) were screened by standard methods (13) .
DNA Sequencing. The EcoRI insert from Agtll was subcloned into pBluescript, and the nucleotide sequence of the PT'Pase insert was obtained by the dideoxy chain-termination technique of Sanger et al. (14) after construction of a series ofnested deletions (15) . In some cases, oligonucleotides were used to obtain additional sequence information in regions not represented by the nested deletions.
Northern (RNA) Blot Analysis. Tissues were quick-frozen and powdered in liquid nitrogen, and total RNA was extracted by the guanidium isothiocyanate method (16 2 x SSC at room temperature and twice in 2x SSC/0.1% NaDodSO4 at 600C (low-stringency) or 0.2x SSC/ 0.1% NaDodSO4 (high-stringency) at 650C. Autoradiograms were exposed as above for 72 hr.
RESULTS
Cloning of the Major Human Placental PTPase. Initially, we attempted to isolate PTP-1B cDNA by screening a human placental cDNA library with a 48-base-pair (bp) "guess-mer" oligonucleotide, designed to correspond to the amino acids from positions 95-110 (7). However, as this approach proved unsuccessful, we chose to use an alternative method. Degenerate oligonucleotides were constructed based on two regions of the protein, as described in Fig. 1 . These regions were chosen to limit the number of possible codon combinations and also to limit the size of the DNA fragment for amplification. In addition, these regions differed from any present in CD45 or LAR to avoid amplifying fragments of those genes. By use of cDNA from a Agtll human placental library as template, a fragment of the expected size was amplified and subsequently subcloned into pBluescript. The sequence of this fragment correctly predicted the known amino acid sequence between the two primers (data not shown).
To obtain the complete cDNA for this enzyme, the PTPase gene fragment was used to probe the human placental cDNA library. A single plaque, with a 3.3-kb insert, hybridized to the probe. The plaque was purified, and the insert was subcloned into pBluescript and sequenced (Fig. 2) . The sequence contains a single long open translational reading frame of 1305 bp, which encodes a protein of435 amino acids. The putative translation inhibition codon at nucleotide 91 conforms to the translation start consensus sequence (A/ G)NNATGG (18) . The open reading frame is terminated by a stop codon (TAG) at nucleotide 13%. A polyadenylylation signal is present at nucleotides 3200-3205, followed by a polyadenylate tract. Over the first 321 residues, the predicted amino acid sequence is in complete agreement with the published amino acid sequence as determined by proteinsequencing techniques. However, the predicted sequence does not terminate at this point but, rather, extends an additional 114 residues before a termination codon is reached. The predicted molecular weight for the phosphatase becomes, then, 49,996 rather than the reported 37,354. We believe that this clone specifies the full-length protein, as the predicted initiating methionine has been found to be blocked by N-acetylation in the authentic protein (7) . It remains possible that alternative forms of the gene are transcribed or that the transcript contains a longer 5' leader sequence, as human PTP-1B mRNA appears somewhat larger than 3.3 kb (see below).
Unlike CD45 and LAR, PTP-1B has no repeated domains. The carboxyl terminus is rich in hydrophobic residues and is unrelated to the carboxyl terminus of the T-cell PTPase. Our deduced amino acid sequence was compared with other reported sequences by using the FASTA algorithm (19) . This analysis revealed weak similarities between the carboxyl terminus of PTP-1B and that of the yeast protein KAR1 (20) , as well as with a short stretch of the hypothetical EpsteinBarr virus protein BALF (21) (data not shown).
in Vitro Translation. mRNA was synthesized by using T7 polymerase from a vector containing the 3.3-kb insert, followed by in vitro translation in the presence of [35Sjmethi-onine (Fig. 3) . The translated protein migrates as an Mr 56,000 protein, 6000 larger than expected. The 5' region of the PTPase clone lacks any ATG codons upstream of the predicted initiating methionine, making it unlikely that the translated protein contains any extra amino acids at the amino terminus. At the carboxyl terminus translation should stop at the TAG codon at position 1396-1399. Although our nucleotide sequence could be in error, this is extremely doubtful, as the sequence of both strands is unambiguous in this region. Posttranslational modifications, which may alter protein mobility on NaDodSO4/acrylamide gels, have not been reported under these conditions in a rabbit reticulocyte lysate. The amino acid composition of PTP-1B does not suggest an obvious explanation for the anomalous migration seen in this experiment. When this cDNA is expressed in Escherichia coli, a highly active PTPase of apparent Mr 56,000 is produced (A.S., unpublished data).
Tissue Distribution of PTP-1B mRNA. Northern blot analysis of RNAs from a variety of human tissues demonstrates that the predominant phosphatase transcript is present as a 3.5-kb species. A second, larger band of -4 kb is also Biochemistry: Chernoff et al. apparent, which could represent the transcript of a related gene or alternately spliced versions of a single primary PTPase message. The strongest hybridizations are to samples from kidney and liver. This pattern of distribution is similar to that observed by direct measurement of PTPase activity (22, 23) .
Gene Structure. Genomic DNA from human placenta and mouse fibroblasts was digested with three restriction enzymes and subjected to Southern blot analysis with the PTPase probe (Fig. 4) . The human placental PTPase gene appears as a single band -7-12 kb in size, unlike the complex pattern for the human T-cell PTPase gene (=70 kb) described by Cool et al. (10) . The pattern for mouse DNA is similar to that seen for human DNA. The simplicity of the hybridization pattern suggests that the gene is present as a single copy in human genomic DNA.
DISCUSSION
In this communication, we describe the molecular cloning of a cDNA corresponding to the major human PTPase previously purified and characterized by Fischer and colleagues (7) . In contrast to their protein sequence analysis, however, the cDNA sequence predicts a protein of Mr 50,000, which contains, in addition to the reported 321 amino acids, an additional 114 (mostly hydrophobic) residues at the carboxyl terminus. We have previously reported the purification of a similar enzyme from bovine brain, termed PTPase-5, which shares many properties with the human placental enzyme but has a Mr of 48,000 (24) . Swarup and Subrahmanyam (25) purified a particulate PTPase from rat spleen that migrated at Mr 50,000 when protease inhibitors were present in homogenization and extraction buffers but only at Mr 36,000 when such precautions were not taken. This reduction in size was accompanied by an increase in enzymatic activity. Similar data have also been reported by others (26) . A plausible explanation for these findings is that the enzyme is normally found in association with the membrane fraction, but that its hydrophobic tail is cleaved during purification, rendering the phosphatase smaller, more soluble, and more active. Conceivably, such proteolytic cleavage and relocation to the cytosol might represent a normal mechanism of enzyme regulation in vivo.
At present, it is difficult to ascribe a physiologic role to any of the particular PTPases. This situation obtains because few key protein targets for tyrosine kinase activity have been identified, despite intense study. PTPase activity has, therefore, been measured by using a variety of widely disparate phosphotyrosyl proteins. In view of the variety of tissues examined and substrates used, it is remarkable that most investigators have found the major PTPase activity to be represented by a protein of Mr 40,000 with similar catalytic properties. Based both on the sequence of the T-cell phosphatase and on the present study, the PTPases of this size appear not to represent a single entity but rather are comprised of a group of proteins of similar size and structure. These enzymes are also closely related to the transmembrane PTPases, such as CD45 and LAR, but differ from them in several vital aspects. Unlike the latter enzymes, the smaller PTPases appear to contain a single catalytic domain. In addition, whereas the activity of CD45 and LAR is presumably regulated by binding of extracellular ligand, different mechanisms must exist for regulating the smaller phosphatases. PTP-1B and the T-cell PTPase are nearly identical over the first =300 amino acids but differ completely at their carboxyl termini. It would not be surprising if regulation of enzymatic activity or substrate specificity were dictated by this region.
Despite the lack of known physiologically significant substrates for tyrosine kinase activity, the PTPase described in this and previous studies is likely to have an important function, as it represents the major activity in most tissues examined. In addition, the markedly hydrophobic character of the carboxyl-terminus sequence of this enzyme suggests that it is membrane-associated, as are the majority of tyrosine kinases (1) and, presumably, at least some of their important substrates. In this context, we note that Tonks and coworkers (7) found that approximately half the PTP-1B activity was found in the particulate fraction.
The availability of PTPase clones may provide an avenue for analyzing the role of tyrosine phosphorylation in various cellular processes. The PTP-1B species may be particularly valuable in this regard, as the in vitro activity of the Mr 38,000 form of this enzyme is lO00 times that of CD45 (in the absence of ligand) (9) . This 
